In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 ...

and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Early identification of the reaction, discontinuation of the medication, and treatment with immunosuppressive agents are ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...

NEW evidence from a large meta-analysis of randomised controlled trials (RCTs) confirms that type 2 inflammatory biomarkers, specifically blood eosinophil count and fractional exhaled nitric oxide ...

Allergens can increase eosinophils, a type of white blood cells, which can exacerbate COPD. Who Should Use Ohtuvayre? Mannino said Ohtuvayre could be right for patients who experience side effects ...

By inhibiting IL-5 signaling, mepolizumab reduces the production and survival of eosinophils, thereby reducing inflammation and exacerbations in patients with eosinophilic COPD. The BLA is supported ...